ESSENTIAL THROMBOCYTOSIS IN CHILDREN

EHA Library, Canan Albayrak, 216528

COEXISTENCE OF JAK2V617F AND CALR MUTATIONS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA IN A SINGLE CENTER.

EHA Library, Maria Saez-Perdomo, 216529

THE EPIDEMIOLOGY AND PRESENTING CLINICAL CHARACTERISTICS OF MYELOPROLIFERATIVE NEOPLASMS IN MALAYSIA

EHA Library, Yee Yee Yap, 216530

THE MORTALITY OUTCOMES AND SURVIVAL PATTERNS OF MPN REGISTRY IN MALAYSIA

EHA Library, Yee Yee Yap, 216531

SECONDARY MALIGNANCIES IN BCR-ABL NEGATIVE CHRONIC MYELOPROLIFERATIVE DISEASES

EHA Library, Eren Arslan Davulcu, 216532

INTRODUCTION OF AN NGS GENE PANEL INTO CLINICAL SERVICE FOR MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Anna Skowronska, 216533

THERAPY OF PATIENTS WITH PREFIBROTIC STAGE OF PRIMARY MYELOFIBROSIS: LONG-TERM EFFECTS.

EHA Library, Eva Burnasheva, 216534

THIOL – DISULPHIDE HOMEOSTASIS IN POLYCYTHEMIA VERA

EHA Library, Aysun SENTURK YIKILMAZ, 216535

EFFICACY AND SAFETY OF RUXOLITINIB IN 132 TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A MULTICENTER AND RETROSPECTIVE ANALYSIS

EHA Library, Guray Saydam, 216536

BLOOD AND BONE MARROW CULTURES FOR THE DIAGNOSIS AND MANAGEMENT OF PRIMARY MYELOFIBROSIS

EHA Library, Tamar Saralidze, 216538

MANAGEMENT OF SYSTEMIC MASTOCYTOSIS IN A SINGLE CENTER EXPERIENCE

EHA Library, Marianna Criscuolo, 216539

ESSENTIAL THROMBOCYTHEMIA ASSOCIATED WITH MASTOCYTOSIS.

EHA Library, Elisabetta COSI, 216540

MORBIDITY AND MORTALITY OF PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: A TERTIARY CENTER EXPERIENCE

EHA Library, Vassilios Papadopoulos, 216541

EPIDEMIOLOGICAL DATA ON POLYCYTHEMIA VERA IN ALBANIA (1999 - 2014)

EHA Library, Adela Perolla, 216542

DECITABINE AS SALVAGE TREATMENT FOR AML TRANSFORMATION OF CHRONIC MYELOPROLIFERATIVE NEOPLASM IN ELDERLY AND UNFIT PATIENTS.

EHA Library, Pasquale Niscola, 216543

FUNCTIONAL IRON DEFICIENCY AND INFLAMMATION IS COMMON IN MYELOFIBROSIS AND CONTRIBUTES TO ANAEMIA AND IMPAIRMENT OF QUALITY OF LIFE.

EHA Library, Gunnar Birgegard, 216544

THE MPN-10 SCORE AND DRIVER MUTATIONS IN THAI MYELOPROLIFERATIVE NEOPLASMS PATIENTS

EHA Library, Naritsara Cherdchoo, 216545

THE EVALUATION OF OXIDATIVE STRESS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND VASCULAR EVENTS

EHA Library, Mihnea-Alexandru Găman, 216546

A NATURAL LANGUAGE PROCESSING ALGORITHM TO AUTOMATICALLY CATEGORIZE DISEASE TYPE AND STATUS FROM FREE-TEXT BONE MARROW MORPHOLOGY REPORTS.

EHA Library, Yu-Fen Wang, 216547

REAL-LIFE EXPERIENCE WITH RUXOLITINIB IN POLYCYTHEMIA VERA PATIENTS RESISTANT OR INTOLERANT TO HYDROXYUREA

EHA Library, Elena González Pérez, 216548

EXPRESSION OF CALRETICULIN AND CD47 IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Kristian BOASMAN, 216549

THE RELEVANCE, EFFICACY AND SAFETY OF ERYTHROPOIETIC-STIMULATING AGENTS (ESAS) IN ANEMIA CONTROL: A RETROSPECTIVE ANALYSIS IN MYELOFIBROSIS PATIENTS IN A SINGLE HOSPITAL.

EHA Library, Harberth Fernandez - Leyva, 216550

LONG TERM CLINICAL OUTCOMES OF MPN PATIENTS WITH JAK2, CALR AND MPL MUTATIONS IN BOSNIA AND HERZEGOVINA: 17 YEARS FOLLOW-UP

EHA Library, Erna Islamagic, 216551

EVALUATION OF THROMBOTIC RISK IN CHRONIC MYELOPROLIFERATIVE NEOPLASMS PATIENTS

EHA Library, Viola Popov, 216552

CHARACTERISTICS OF PATIENTS WITH JAK2 EXON 12 MUTATED POLYCYTHEMIA VERA

EHA Library, Tatiana Subbotina, 216553

A RETROSPECTIVE STUDY OF PATIENTS WITH POLYCYTHEMIA PRESENTING TO A COMMUNITY HAEMATOLOGIST: NOT ALL INCREASED HEMOGLOBIN IS POLYCYTHEMIA VERA

EHA Library, Nitin Gupta, 216554

RUXOLITINIB AND VITAMIN K ANTAGONISTS(VKA) IS SAFE AND EFFECTIVE AND SHOWS A FASTER RECANALIZATION AND AN ANTINFLAMMATORY EFFECT IN PRIMARY MYELOFIBROSIS(PMF) WITH SPLANCHNIC VEIN THROMBOSIS(SVT).

EHA Library, GIULIO GIORDANO, 216555

SPLANCHNIC THROMBOSES IN MYELOPROLIFERATIVE DISORDERS - EXPERIENCE OF THE HEMATOLOGY CENTER OF FUNDENI CLINICAL INSTITUTE

EHA Library, Iulia Ursuleac, 216556

IMMATURE PLATELET PARAMETERS FOR PREDICTION OF POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA IN PATIENTS WITH ELEVATED PLATELET COUNTS

EHA Library, Jung Yoon, 216557

MLPA ASSAY USED FOR VERIFICATION OF RARE FINDING: SPORADIC PRESENCE OF TWO CALR MUTATIONS IN ONE PMF PATIENT

EHA Library, Hana Drimalova, 216558

JAK2V617F MUTATION AS A RISK FACTOR FOR INCIDENCE OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Evica Simonovic, 216559

RISK FACTORS FOR INCIDENCE OF HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA

EHA Library, Evica Simonovic, 216560

TREATMENT WITH RUXOLITINIB FOR MYELOID MYELOFIBROSIS - THE EXPERIENCE OF SINGLE CENTRE

EHA Library, Ana Maria Moldovianu, 216561

OXIDATIVE STRESS IN PRIMARY AND SECONDARY MYELOFIBROSIS: IS THERE A ROLE FOR THE JAK2V617F MUTATION OR EXTRAMEDULLARY HEMATOPOIESIS SITES?

EHA Library, Mihnea-Alexandru Găman, 216562

RUXOLITINIB IN MYELOFIBROSIS: THE NORTHERN IRELAND EXPERIENCE

EHA Library, James Russell, 216563

A SINGLE-CENTER RETROSPECTIVE ANALYSIS OF AUTOIMMUNE MYELOFIBROSIS (AIMF). AIMF ASSOCIATED WITH COMMON VARIABLE IMMUNODEFICIENCY AND RELAPSING-REMITTING MULTIPLE SCLEROSIS.

EHA Library, Marta García-Recio, 216564

IMMUNOHISTOCHEMISTRY AS A TOOL TO DETECT CALRETICULIN MUTATION IN PATIENTS OF PRIMARY MYELOFIBROSIS AND ESSENTIAL THROMBOCYTHEMIA AND ITS COMPARISON WITH POLYMERASE CHAIN REACTION

EHA Library, Aastha Gupta, 216565

HODGKIN LYMPHOMA IN ADOLESCENTS TREATED WITH ABVD

EHA Library, S.M.Amine BENLAZAR, 216566

HODGKIN LYMPHOMA OF THE GASTROINTESTINAL TRACT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

EHA Library, Merav Barzilai, 216567

REAL WORLD DATA ON THE EFFICACY AND SAFETY OF BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY HODGIN LYMPHOMA IN SLOVAKIA

EHA Library, Miriam Ladicka, 216568

PET-CR +2 METABOLIC RESPONSE GUIDED TREATMENT IN PEDIATRIC HODGKIN LYMPHOMA PATIENTS

EHA Library, Vassilios Papadakis, 216569

INTERIM POSITRON EMISSION TOMOGRAPHY AND CHILDHOOD HODGKIN INTERNATIONAL PROGNOSTIC SCORE CAN PREDICT SURVIVAL OF CHILDREN WITH HODGKIN LYMPHOMA IN DEVELOPING COUNTRIES

EHA Library, Reham Khedr, 216570

THE PERIPHERAL BLOOD ILC, AND TH-17 RELATED CYTOKINE PRODUCTION ARE IMPAIRED IN A CHILD WITH A NOVEL MUTATION IN ITK WHO PRESENTED WITH RELAPSED HODGKIN LYMPHOMA

EHA Library, Turkan Patıroglu, 216571

A CLINICAL CASE OF IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH PD-1 INHIBITOR (NIVOLUMAB) TREATMENT IN A PATIENT WITH RECURRING HODGKIN'S LYMPHOMA

EHA Library, Maxim Platonov, 216572

PD-1 INHIBITORS IN THE TREATMENT OF RELAPSED AND REFRACTORY CLASSICAL HODGKIN'S LYMPHOMA

EHA Library, Maria Kichigina, 216574

A FAMILIAL REPORT OF MIXED CELLULARITY HODGKIN’S DISEASE(HD): THE SAME SUBTYPE HD, EBV NEGATIVE, WITH DIFFERENT OUTCOME.

EHA Library, Maria Moschovi, 216575

SUCCESSFUL TREATMENT WITH NIVOLUMAB OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SECONDARY TO REFRACTORY HODGKIN LYMPHOMA. A CASE REPORT.

EHA Library, Chiara Cantò, 216576

TREATMENT OUTCOMES FOR HODGKIN LYMPHOMA WITH BULKY MEDIASTINAL DISEASE (2BX): HOSPITAL AMPANG’S EXPERIENCE

EHA Library, Siongleng HON, 216577

CLASSICAL HODGKIN LYMPHOMA TREATMENT PATTERNS, MOLECULAR PROFILING, AND CLINICAL OUTCOMES IN US ONCOLOGY PRACTICES: A PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Chris Yasenchak, 216578

HODGKIN LYMPHOMA: THE MOFFITT CANCER CENTER EXPERIENCE

EHA Library, Ashley Rose, 216579

PROGNOSTIC SIGNIFICANCE OF NEUTROPHIL LYMPHOCYTE RATIO (NLR) IN NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL)

EHA Library, Semra Paydas, 216580

¬PROGNOSTIC FACTORS OF SURVIVAL IN ADOLESCENT AND YOUNG ADULT (AYA) PATIENTS WITH EARLY-STAGE CLASSICAL HODGKIN LYMPHOMA ACCORDING TO SUBTYPE: A 15-YEAR STUDY IN A PERUVIAN SINGLE CANCER CENTER

EHA Library, Jule Vasquez, 216581

LONG-TERM ENDOCRINOLOGIC SIDE EFFECTS OF CHILDHOOD HODGKIN’S LYMPHOMA TREATMENT

EHA Library, Gonul AYDOGAN, 216582

THE PROGNOSTIC SIGNIFICANCE OF EXTRANODAL DISEASE IN HODGKIN’S LYMPHOMA

EHA Library, S.M.Amine BENLAZAR, 216583

PREGNANCY RATE AND RISK OF RELAPSE IN PATIENTS IN COMPLETE REMISSION AFTER HODGKIN'S LYMPHOMA.

EHA Library, Francesco Gaudio, 216584

EFFECT OF THE INITIAL TREATMENT ON THE MUSCLE MASS AND RESPONSE TO THERAPY IN HODGKIN’S LYMPHOMA

EHA Library, Selin Kucukyurt Kaya, 216585

RISK FACTORS FOR SECOND MALIGNANCES IN HODGKIN LYMPHOMA TREATED WITH ABVD: A SINGLE CENTER EXPERIENCE.

EHA Library, Elías Fernando Palma Zamora, 216586

ABSOLUTE LYMPHOCYTE COUNT AND LYMPHOCYTE-MONOCYTE RELATIONSHIP AS A PROGNOSTIC CRITERIA IN HODGKIN’S LYMPHOMA.

EHA Library, Anatolij Rukavitcyn, 216587

PHENOTYPIC CHARACTERIZATION OF CIRCULATING T AND NK CELLS IN HODGKIN LYMPHOMA (HL) PATIENTS IN RELATION TO TUMOR BURDEN

EHA Library, Tom Aadrian Mulder, 216588

EPSTEIN - BARR VIRUS EXPRESSION IN HODGKIN’S LYMPHOMA IN SUDAN

EHA Library, Enaam Hussein, 216590

FINE-NEEDLE-ASPIRATION: IS IT A USEFUL DIAGNOSTIC TOOL?

EHA Library, Ángela Gil, 216591

THE COMPREHENSIVE DESCRIPTION OF TP53 GENE ABERRATIONS IN DLBCL

EHA Library, Elena Voropaeva, 216592

SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IS CAUSED BY THE DEFICIENCY OF ESSENTIAL AMINO ACID TRYPTOPHAN

EHA Library, Soranobu Ninomiya, 216593

POTENT MYC AND RUNX COLLABORATION IN LYMPHOMA PERTURBS T-CELL RECEPTOR SIGNALLING AND ATTENUATES P53 TRANSACTIVATION

EHA Library, Jodie Hay, 216594

INTEGRATION OF BIOINFORMATICS AND EXPERIMENTS TO IDENTIFY TP53 AS A POTENTIAL TARGET IN EMODIN INHIBITING NON–HODGKIN’S LYMPHOMA

EHA Library, Jianda Hu, 216595

CORRELATION BETWEEN CLINICAL ANT PATHOLOGICAL VARIABLES WITH IMMUNOHISTOCHEMICALLY DIFFERENTIATED MOLECULAR SUBTYPES OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Emina Hadzimesic, 216596

THE UTILITY OF THE FORWARD SCATTER PARAMETER IN THE FLOW-CYTOMETRIC EVALUATION OF LYMPH NODE CELL SUSPENSION TO IDENTIFY B CELL LYMPHOMAS

EHA Library, Francesco Corrente, 216597

EZH2 GENE UPREGULATION IN PRIMARY TESTICULAR AND CENTRAL NERVOUS SYSTEM DIFFUSE LARGE B-CELL LYMPHOMA: A POTENTIAL TARGET FOR TREATMENT IN IMMUNE-PRIVILEGED SITES?

EHA Library, Deniz Peker, 216598

THE IMPAIRED PRODUCTION OF TNF, TGF BETA 1 AS AN IMPORTANT REASON OF DEFECTIVE NATURAL KILLER ABILITY IN NON-HODGKIN LYMPHOMA PATIENTS WITH SPLEEN AFFECTION

EHA Library, Vira Barilka, 216599

NEW POTENTIAL CANDIDATE GENES IN MANTLE CELL LYMPHOMA

EHA Library, Oriane Cédile, 216600

BONE MARROW STROMAL MICROENVIRONMENT PRECURSOR CELLS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA WITHOUT BONE MARROW INVOLVEMENT

EHA Library, Ekaterina Fastova, 216601

LYMPH NODE ASSESSMENT BY CYTOLOGY AND MULTIPARAMETRIC FLOW CYTOMETRY: A PROSPECTIVE STUDY OF 176 SAMPLES

EHA Library, Zuriñe DIEZ GALLARRETA, 216602

IGHV GENES AND STEREOTYPIC RECEPTORS IN DIFFERENT B-CELL MALIGNANCIES

EHA Library, Bella Biderman, 216603

THREE-DIMENSIONAL CULTURING INDUCES CHEMORESISTANCE AND INVASIVE CAPACITY OF MOUSE LYMPHOMA CELLS BY UPREGULATION TIAM-1/NOTCH

EHA Library, Muhmmad Ikram, 216604

THE ROLE OF MULTIPARAMETER FLOW CYTOMETRY IN THE WORK-UP OF IGM-MONOCLONAL GAMMOPATHIES

EHA Library, Anna Mestice, 216605

ACTIVATION INDUCED CYTIDINE DEAMINASE IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Lewis Vanhinsbergh, 216606

MICROVASCULAR DENSITY, CD68 AND TRYPTASE EXPRESSION IN HUMAN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Domenico Ribatti, 216607

DETECTION OF MINOR BLOOD INVOLVEMENT IN MYCOSIS FUNGOIDES: PROGNOSTIC IMPLICATIONS

EHA Library, M Teresa Cedena, 216608

DUODENAL-TYPE FOLLICULAR LYMPHOMA: WHICH IS THE BEST THERAPEUTIC OPTION?

EHA Library, Filipa Saraiva, 216609

THE IMPACT OF FIRST COMPLETE REMISSION BY PET-CT AND TIME TO NEXT TREATMENT ON OVERALL SURVIVAL OF FOLLICULAR LYMPHOMA PATIENTS

EHA Library, Tran-Der Tan, 216610

RITUXIMAB MAINTENANCE IMPROVES SURVIVAL IN FOLLICULAR LYMPHOMA: A RETROSPECTIVE NATIONWIDE REAL-WORLD ANALYSIS FROM TAIWAN CANCER REGISTRY

EHA Library, Huai-Hsuan Huang, 216611

RISK FOR REACTIVATION OF HEPATITIS B INFECTION - IMPROVING TESTING PRE-IMMUNOCHEMOTHERAPY

EHA Library, Chin Neoh, 216612

SINGLE-CENTER EXPERIENCE WITH BENDAMUSTINE-BASED IMMUNOCHEMOTERAPY REGIMENS IN INDOLENT LYMPHOID MALIGNANCIES AND MANTLE-CELL LYMPHOMA

EHA Library, Barbara Dreta, 216613

HAIRY CELL LEUKEMIA: 20-YEAR SINGLE CENTER EXPERIENCE

EHA Library, Marianna Criscuolo, 216614

A RETROSPECTIVE REVIEW OF EXPERIENCE IN DELIVERING MAINTENANCE RITUXIMAB FOR FOLLICULAR LYMPHOMA IN A DISTRICT GENERAL HOSPITAL.

EHA Library, Angharad Pryce, 216615

GASTRIC MALT LYMPHOMA : A MONOCENTRIC STUDY

EHA Library, Moez medhaffar, 216617

CLINICAL FEATURES AND TREATMENT OUTCOMES OF LIMITED STATE MANTLE CELL LYMPHOMA (CISL16-06)

EHA Library, Jae-Cheol Jo, 216618

HAIRY CELL LEUKAEMIA - SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS – UNICENTRIC EXPERIENCE

EHA Library, Diana Mota, 216619

IS DA-EPOCH -/+ RITUXIMAB FOR AGGRESSIVE LYMPHOMA FEASIBLE AND EFFECTIVE IN CLINICAL PRACTICE? A RETROSPECTIVE STUDY.

EHA Library, Shinichiro Matsuda, 216620

CLINICAL IMPACT OF PROGNOSTIC NUTRITIONAL INDEX IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Gyeong-Won Lee, 216621

VEINO-OCCLUSIVE DISEASE (VOD) DURING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): WARNING ABOUT SUSPECTED INCREASED INCIDENCE AFTER OXALIPLATIN-CONTAINING SALVAGE REGIMEN

EHA Library, Pierre-Edouard Debureaux, 216622

COMPARISON BETWEEN CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING AND 18F-FDG POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY FOR THE DIAGNOSIS OF NEUROLYMPHOMATOSIS

EHA Library, Yoshiaki Abe, 216623

MODIFIED R-IDARAM TREATMENT IN CENTRAL NERVOUS SYSTEM LYMPHOMAS: A SINGLE CENTRE EXPERIENCE

EHA Library, Senem Maral, 216624

A PHASE IB, OPEN LABEL, MULTICENTER TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20-POSITIVE TUMORS, RITUXIMAB (PREBEN) IN RELAPSED AGGRESSIVE LYMPHOMAS OF B- OR T-CELL PHENOTYPE

EHA Library, F D'Amore, 216625

‘REAL WORLD’ PRESENTATIONS OF DIFFUSE LARGE B CELL LYMPHOMA: A RETROSPECTIVE AUDIT OF HISTOPATHOLOGICAL & CLINICAL DIVERSITY, & EARLY MORTALITY

EHA Library, Abishan Thavarajah, 216626

EARLY MORTALITY IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA

EHA Library, Chia-Jen Liu, 216627

LONG-LASTING RESPONSES WITH EXTRACORPOREAL PHOTOPHERESIS FOR SÉZARY SYNDROME. SINGLE CENTER EXPERIENCE.

EHA Library, Marcio Miguel Andrade Campos, 216628

FEASIBILITY OF PIXANTRONE CONTAINING R-CPOP AS FIRST LINE TREATMENT FOR PATIENTS WITH AGGRESSIVE B CELL LYMPHOMA WITH CONGESTIVE HEART FAILURE OR AT RISK OF ANTHRACYCLINE INDUCED CARDIOTOXICITY

EHA Library, Reinhard MARKS, 216629

PLEURAL EFFUSION IN PATIENTS WITH NON-HODGKIN LYMPHOMA

EHA Library, Adriana Roque, 216630

EXPRESSION AND CLINICAL RELEVANCE OF PROGRAMMED CELL DEATH-1 AND PROGRAMMED CELL DEATH LIGANDS IN EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA

EHA Library, Hamidah Muhamad, 216631